{
    "Trade/Device Name(s)": [
        "InPlex CF Molecular Test"
    ],
    "Submitter Information": "Third Wave Technologies, Inc.",
    "510(k) Number": "K063787",
    "Predicate Device Reference 510(k) Number(s)": [
        "K043011"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NUA"
    ],
    "Summary Letter Date": "March 7, 2008",
    "Summary Letter Received Date": "March 10, 2008",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.5900"
    ],
    "Regulation Name(s)": [
        "Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutation detection system"
    ],
    "Analyte Class(es)": [
        "genetic molecular"
    ],
    "Analyte(s)": [
        "CFTR gene mutations",
        "IVS8-5T/7T/9T variants"
    ],
    "Specimen Type(s)": [
        "Whole blood",
        "Genomic DNA"
    ],
    "Specimen Container(s)": [
        "EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "InPlex microfluidic card",
        "Multi-well fluorometer"
    ],
    "Method(s)/Technology(ies)": [
        "Multiplex PCR",
        "Invader reaction",
        "Genomic DNA extraction"
    ],
    "Methodologies": [
        "Mutation detection",
        "Genotyping"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit",
        "Software",
        "Microfluidic card"
    ],
    "Document Summary": "FDA 510(k) summary for InPlex CF Molecular Test for simultaneous detection and identification of ACMG/ACOG-recommended CFTR gene mutations using microfluidic card technology",
    "Indications for Use Summary": "Intended for in vitro qualitative genotyping of CFTR gene mutations in genomic DNA from human peripheral whole blood to aid carrier screening for adults of reproductive age, assist in newborn screening, and confirmatory testing in newborns and children; not for fetal or pre-implantation testing or stand-alone diagnostics.",
    "fda_folder": "Immunology"
}